Skip to main content
. 2010 Apr 15;6(2):169–175.

Table 2.

Means (SD) of sleep parameters comparing sleep restriction therapy and hypnotic withdrawal condition (SR+HW; n = 22) and sleep hygiene education condition (SHE; n = 17) conditions at pre-treatment and post-treatment

Variable Pre-TX
Post-TX
6-mo FU
12-mo FU
Pre-post × Condition
M (SD) M (SD) M (SD) M (SD) Δ df F p Cohen's d
    SE (%) 1 9.98 0.003 1.16
        SR+HW 70.66 (11.77) 87.77 (7.00) 88.07 (7.81) 86.62 (9.58) 17.11
        SHE 70.50 (10.12) 75.98 (11.50) 5.48
    TST (min) 1 2.50 0.122
        SR+HW 346.72 (62.98) 339.46 (57.60) 395.41 (43.64) 390.71 (51.33) −7.26
        SHE 320.67 (57.65) 343.80 (69.50) 23.13
    SOL (min) 1 5.17 0.029 0.56
        SR+HW 57.60 (33.28) 23.18 (22.98) 22.28 (20.55) 23.24 (19.08) −34.42
        SHE 56.36 (33.85) 40.18 (31.76) −16.18
    WASO (min) 1 4.02 0.052 0.57
        SR+HW 56.17 (32.87) 14.96 (8.66) 22.37 (15.82) 26.92 (30.27) −41.21
        SHE 49.97 (32.89) 30.08 (23.95) −19.89
    TWAK (min) 1 13.29 0.001 1.06
        SR+HW 38.83 (29.95) 10.96 (11.00) 16.71 (16.71) 22.97 (15.99) −27.87
        SHE 40.74 (34.53) 43.50 (43.00) 2.76
    Drugs (doses/wk) 1 19.48 < 0.001 1.05
        SR+HW 1.25 (0.90) 0.28 (0.45) 0.17 (0.34) 0.18 (0.35) −0.97
        SHE 1.13 (0.86) 1.11 (0.93) −0.02

All effect size calculations were performed with conventions from the ES software package using Data Source 0801: Two-Factor (conditions × Time) repeated-measures ANOVA.

TX, treatment; FU, follow-up; SR+HW, sleep restriction therapy and hypnotic withdrawal condition; SHE, sleep hygiene education condition; SOL, sleep onset latency; WASO, wake time after sleep onset; TWAK, final wakefulness (amount of awake time between the final awakening and the time of getting out of bed); SE, sleep efficiency; TST, total sleep time.